| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2021 | 249 | 0.74 | Why? |
| Basigin | 1 | 2020 | 276 | 0.69 | Why? |
| Dipeptidyl Peptidase 4 | 2 | 2021 | 1061 | 0.67 | Why? |
| Polymorphism, Single Nucleotide | 13 | 2021 | 3607 | 0.58 | Why? |
| Genetic Predisposition to Disease | 15 | 2021 | 4027 | 0.57 | Why? |
| Nevirapine | 3 | 2018 | 57 | 0.52 | Why? |
| Induced Pluripotent Stem Cells | 4 | 2020 | 584 | 0.51 | Why? |
| Myotonic Dystrophy | 3 | 2018 | 51 | 0.50 | Why? |
| Furin | 1 | 2020 | 1054 | 0.50 | Why? |
| Peptide Fragments | 1 | 2021 | 2075 | 0.42 | Why? |
| Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 2 | 2019 | 9 | 0.37 | Why? |
| STAT4 Transcription Factor | 2 | 2019 | 16 | 0.37 | Why? |
| Myotonia Congenita | 2 | 2017 | 6 | 0.36 | Why? |
| Mutation | 7 | 2021 | 12376 | 0.36 | Why? |
| Aging, Premature | 2 | 2017 | 11 | 0.35 | Why? |
| Chloride Channels | 2 | 2017 | 51 | 0.35 | Why? |
| Stevens-Johnson Syndrome | 3 | 2018 | 129 | 0.34 | Why? |
| Scavenger Receptors, Class E | 2 | 2017 | 50 | 0.33 | Why? |
| HLA-C Antigens | 2 | 2018 | 195 | 0.31 | Why? |
| Volatile Organic Compounds | 2 | 2018 | 187 | 0.29 | Why? |
| Alleles | 6 | 2021 | 1557 | 0.28 | Why? |
| Phenotype | 7 | 2020 | 4037 | 0.28 | Why? |
| Cell Differentiation | 4 | 2018 | 1338 | 0.28 | Why? |
| Serine Endopeptidases | 1 | 2020 | 4606 | 0.27 | Why? |
| Progeria | 2 | 2018 | 2 | 0.27 | Why? |
| Abdominal Wound Closure Techniques | 2 | 2018 | 19 | 0.24 | Why? |
| Peptidyl-Dipeptidase A | 2 | 2020 | 9659 | 0.23 | Why? |
| Metalloendopeptidases | 2 | 2018 | 35 | 0.23 | Why? |
| Nedd4 Ubiquitin Protein Ligases | 1 | 2021 | 43 | 0.23 | Why? |
| Genotype | 10 | 2020 | 4697 | 0.23 | Why? |
| Pharmacogenetics | 3 | 2017 | 222 | 0.23 | Why? |
| Endosomal Sorting Complexes Required for Transport | 1 | 2021 | 67 | 0.23 | Why? |
| Adaptor Proteins, Signal Transducing | 3 | 2020 | 502 | 0.22 | Why? |
| Macular Degeneration | 2 | 2017 | 194 | 0.22 | Why? |
| Host-Pathogen Interactions | 2 | 2021 | 11041 | 0.21 | Why? |
| MicroRNAs | 3 | 2019 | 1787 | 0.21 | Why? |
| Digestive System Surgical Procedures | 2 | 2018 | 677 | 0.21 | Why? |
| Anti-HIV Agents | 3 | 2018 | 2209 | 0.21 | Why? |
| Mice, Inbred BALB C | 2 | 2021 | 5814 | 0.21 | Why? |
| Connexins | 1 | 2019 | 30 | 0.20 | Why? |
| Keratoderma, Palmoplantar | 1 | 2019 | 24 | 0.20 | Why? |
| Ubiquitination | 1 | 2021 | 343 | 0.20 | Why? |
| Membrane Proteins | 3 | 2018 | 1733 | 0.19 | Why? |
| Abdominal Cavity | 1 | 2018 | 22 | 0.19 | Why? |
| Exome | 1 | 2020 | 207 | 0.19 | Why? |
| Retinitis Pigmentosa | 1 | 2018 | 14 | 0.19 | Why? |
| Acro-Osteolysis | 1 | 2017 | 2 | 0.19 | Why? |
| DNA Repeat Expansion | 1 | 2017 | 5 | 0.19 | Why? |
| Genetic Diseases, X-Linked | 1 | 2021 | 237 | 0.18 | Why? |
| Lipodystrophy | 1 | 2017 | 18 | 0.18 | Why? |
| Intestinal Fistula | 1 | 2018 | 43 | 0.18 | Why? |
| Loss of Function Mutation | 1 | 2020 | 244 | 0.18 | Why? |
| Hypopituitarism | 1 | 2018 | 64 | 0.18 | Why? |
| Whole Exome Sequencing | 1 | 2020 | 437 | 0.18 | Why? |
| Protein Tyrosine Phosphatase, Non-Receptor Type 2 | 1 | 2017 | 3 | 0.17 | Why? |
| Glutathione Transferase | 1 | 2017 | 86 | 0.17 | Why? |
| Pharmacogenomic Testing | 1 | 2018 | 115 | 0.17 | Why? |
| Clusterin | 1 | 2016 | 7 | 0.17 | Why? |
| Toll-Like Receptor 7 | 1 | 2021 | 402 | 0.17 | Why? |
| Lamin Type A | 3 | 2018 | 14 | 0.17 | Why? |
| Mandible | 1 | 2017 | 72 | 0.17 | Why? |
| Ku Autoantigen | 1 | 2016 | 11 | 0.17 | Why? |
| Abortion, Habitual | 1 | 2017 | 35 | 0.17 | Why? |
| Diabetic Neuropathies | 1 | 2017 | 64 | 0.17 | Why? |
| Hearing Loss, Sensorineural | 1 | 2019 | 159 | 0.17 | Why? |
| Pharmacogenomic Variants | 1 | 2017 | 112 | 0.17 | Why? |
| Nevus | 1 | 2016 | 42 | 0.16 | Why? |
| Alternative Splicing | 1 | 2017 | 82 | 0.16 | Why? |
| Immune System Diseases | 1 | 2021 | 410 | 0.16 | Why? |
| Chemoradiotherapy, Adjuvant | 1 | 2016 | 69 | 0.16 | Why? |
| Antiparkinson Agents | 1 | 2018 | 125 | 0.16 | Why? |
| Gene Editing | 1 | 2020 | 330 | 0.16 | Why? |
| Haplotypes | 1 | 2020 | 853 | 0.16 | Why? |
| DNA Methylation | 2 | 2019 | 688 | 0.16 | Why? |
| Vero Cells | 3 | 2021 | 14117 | 0.15 | Why? |
| Genetic Variation | 2 | 2020 | 3919 | 0.15 | Why? |
| Skin | 2 | 2019 | 2096 | 0.15 | Why? |
| Proteins | 2 | 2017 | 921 | 0.15 | Why? |
| Genetic Therapy | 1 | 2020 | 409 | 0.15 | Why? |
| Sjogren's Syndrome | 1 | 2019 | 284 | 0.15 | Why? |
| Gene Frequency | 5 | 2020 | 1210 | 0.15 | Why? |
| Public Health | 1 | 2020 | 16359 | 0.14 | Why? |
| Spike Glycoprotein, Coronavirus | 3 | 2021 | 37182 | 0.14 | Why? |
| Genetic Association Studies | 4 | 2019 | 559 | 0.14 | Why? |
| HLA Antigens | 1 | 2020 | 830 | 0.14 | Why? |
| Population Health | 1 | 2021 | 504 | 0.14 | Why? |
| Chemoradiotherapy | 1 | 2016 | 362 | 0.13 | Why? |
| RNA, Long Noncoding | 1 | 2019 | 408 | 0.13 | Why? |
| Abdomen | 1 | 2017 | 424 | 0.13 | Why? |
| Neoadjuvant Therapy | 1 | 2016 | 554 | 0.13 | Why? |
| Pyrroline Carboxylate Reductases | 1 | 2012 | 3 | 0.12 | Why? |
| Epigenesis, Genetic | 1 | 2019 | 711 | 0.12 | Why? |
| Corneal Opacity | 1 | 2012 | 7 | 0.12 | Why? |
| Cutis Laxa | 1 | 2012 | 5 | 0.12 | Why? |
| Humans | 50 | 2021 | 930598 | 0.12 | Why? |
| Mice | 3 | 2021 | 21357 | 0.12 | Why? |
| Pneumonia, Viral | 8 | 2020 | 243684 | 0.12 | Why? |
| Metabolome | 1 | 2017 | 624 | 0.12 | Why? |
| Indoles | 1 | 2021 | 1243 | 0.12 | Why? |
| Coronavirus Infections | 8 | 2020 | 253789 | 0.12 | Why? |
| Aryl Hydrocarbon Hydroxylases | 1 | 2011 | 5 | 0.12 | Why? |
| Rectal Neoplasms | 1 | 2016 | 278 | 0.12 | Why? |
| Interleukin-10 | 1 | 2019 | 1409 | 0.11 | Why? |
| Myocytes, Cardiac | 1 | 2018 | 804 | 0.11 | Why? |
| Neoplasm Proteins | 1 | 2016 | 501 | 0.11 | Why? |
| Pedigree | 3 | 2021 | 502 | 0.11 | Why? |
| CRISPR-Cas Systems | 1 | 2020 | 1397 | 0.11 | Why? |
| Drug Hypersensitivity | 1 | 2017 | 401 | 0.11 | Why? |
| Models, Molecular | 2 | 2021 | 7616 | 0.10 | Why? |
| RNA-Binding Proteins | 1 | 2017 | 1022 | 0.10 | Why? |
| Epitopes, T-Lymphocyte | 1 | 2021 | 2262 | 0.10 | Why? |
| Adult | 19 | 2021 | 244371 | 0.10 | Why? |
| Middle Aged | 20 | 2021 | 270681 | 0.10 | Why? |
| INDEL Mutation | 1 | 2009 | 128 | 0.10 | Why? |
| Pandemics | 10 | 2021 | 389249 | 0.09 | Why? |
| Aged, 80 and over | 10 | 2021 | 88759 | 0.09 | Why? |
| Betacoronavirus | 6 | 2020 | 204454 | 0.09 | Why? |
| Thromboembolism | 1 | 2021 | 2101 | 0.09 | Why? |
| Aged | 15 | 2021 | 215776 | 0.09 | Why? |
| Vaccines, Synthetic | 1 | 2021 | 3231 | 0.09 | Why? |
| Cellular Reprogramming | 2 | 2020 | 117 | 0.09 | Why? |
| Protein Domains | 1 | 2021 | 6563 | 0.09 | Why? |
| Molecular Dynamics Simulation | 1 | 2021 | 4155 | 0.09 | Why? |
| Crohn Disease | 1 | 2017 | 959 | 0.09 | Why? |
| Genomics | 1 | 2020 | 3118 | 0.09 | Why? |
| Thrombocytopenia | 1 | 2021 | 2093 | 0.09 | Why? |
| Protein Binding | 2 | 2021 | 11430 | 0.09 | Why? |
| Mozambique | 2 | 2018 | 205 | 0.09 | Why? |
| Animals | 7 | 2021 | 78931 | 0.09 | Why? |
| Genetic Loci | 2 | 2020 | 439 | 0.09 | Why? |
| Gas Chromatography-Mass Spectrometry | 2 | 2018 | 187 | 0.08 | Why? |
| Child, Preschool | 7 | 2021 | 36283 | 0.08 | Why? |
| Precision Medicine | 1 | 2017 | 1477 | 0.08 | Why? |
| Child | 7 | 2021 | 70012 | 0.08 | Why? |
| Politics | 1 | 2020 | 1824 | 0.08 | Why? |
| Interferon Type I | 1 | 2020 | 2789 | 0.08 | Why? |
| Arthritis, Rheumatoid | 2 | 2020 | 2043 | 0.08 | Why? |
| RNA Splicing | 2 | 2018 | 119 | 0.08 | Why? |
| Periodicals as Topic | 1 | 2020 | 1492 | 0.08 | Why? |
| Diabetes Mellitus, Type 2 | 2 | 2019 | 6166 | 0.08 | Why? |
| Female | 22 | 2021 | 380317 | 0.08 | Why? |
| Leadership | 1 | 2020 | 2241 | 0.08 | Why? |
| Male | 21 | 2021 | 367725 | 0.08 | Why? |
| Warfarin | 1 | 2011 | 402 | 0.08 | Why? |
| Tumor Necrosis Factor-alpha | 1 | 2017 | 2483 | 0.08 | Why? |
| Drug Discovery | 1 | 2020 | 3092 | 0.08 | Why? |
| Protein Isoforms | 2 | 2017 | 347 | 0.08 | Why? |
| Myocardium | 1 | 2018 | 2323 | 0.08 | Why? |
| Mosaicism | 1 | 2005 | 44 | 0.08 | Why? |
| Intellectual Disability | 1 | 2012 | 391 | 0.08 | Why? |
| Molecular Docking Simulation | 1 | 2021 | 6902 | 0.07 | Why? |
| Adolescent | 6 | 2021 | 86841 | 0.07 | Why? |
| Computer Simulation | 1 | 2020 | 4982 | 0.07 | Why? |
| Principal Component Analysis | 2 | 2018 | 689 | 0.07 | Why? |
| Parkinson Disease | 1 | 2018 | 1414 | 0.07 | Why? |
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 3633 | 0.07 | Why? |
| Italy | 5 | 2020 | 38444 | 0.07 | Why? |
| Coronary Artery Disease | 1 | 2019 | 2570 | 0.07 | Why? |
| Antibodies, Neutralizing | 2 | 2021 | 25288 | 0.07 | Why? |
| Diabetes Mellitus, Type 1 | 1 | 2019 | 1969 | 0.07 | Why? |
| Internationality | 1 | 2017 | 3297 | 0.07 | Why? |
| Population Surveillance | 1 | 2020 | 4967 | 0.07 | Why? |
| Case-Control Studies | 6 | 2019 | 17671 | 0.06 | Why? |
| Autoimmune Diseases | 1 | 2017 | 1996 | 0.06 | Why? |
| India | 1 | 2021 | 11875 | 0.06 | Why? |
| Young Adult | 8 | 2021 | 93724 | 0.06 | Why? |
| Skin Neoplasms | 1 | 2016 | 1679 | 0.06 | Why? |
| Pharmaceutical Preparations | 1 | 2017 | 1897 | 0.06 | Why? |
| Virus Diseases | 1 | 2020 | 3779 | 0.06 | Why? |
| Virus Internalization | 1 | 2021 | 7921 | 0.06 | Why? |
| Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 1 | 2021 | 73 | 0.06 | Why? |
| Genome-Wide Association Study | 2 | 2021 | 1648 | 0.06 | Why? |
| Interleukin-6 | 1 | 2020 | 7522 | 0.06 | Why? |
| Penetrance | 1 | 2021 | 121 | 0.06 | Why? |
| HIV Infections | 2 | 2018 | 11620 | 0.06 | Why? |
| Antibodies, Monoclonal | 1 | 2021 | 8041 | 0.06 | Why? |
| TYK2 Kinase | 1 | 2021 | 116 | 0.06 | Why? |
| Nervous System Diseases | 1 | 2020 | 4092 | 0.06 | Why? |
| Aging | 1 | 2017 | 3581 | 0.05 | Why? |
| Vitamin D | 1 | 2016 | 2904 | 0.05 | Why? |
| Manuscripts as Topic | 1 | 2020 | 17 | 0.05 | Why? |
| Health Policy | 1 | 2021 | 6242 | 0.05 | Why? |
| Connexin 26 | 1 | 2019 | 9 | 0.05 | Why? |
| Polymorphism, Genetic | 2 | 2019 | 1074 | 0.05 | Why? |
| Models, Biological | 1 | 2018 | 4907 | 0.05 | Why? |
| Interferon Regulatory Factor-7 | 1 | 2020 | 234 | 0.05 | Why? |
| Antigens, Differentiation, T-Lymphocyte | 1 | 2020 | 146 | 0.05 | Why? |
| Embryoid Bodies | 1 | 2018 | 9 | 0.05 | Why? |
| Chromatography, Gas | 1 | 2018 | 25 | 0.05 | Why? |
| Genes, Recessive | 1 | 2018 | 35 | 0.05 | Why? |
| Cell Nucleus Shape | 1 | 2018 | 2 | 0.05 | Why? |
| Lamins | 1 | 2018 | 3 | 0.05 | Why? |
| Consanguinity | 1 | 2018 | 50 | 0.05 | Why? |
| Monoamine Oxidase Inhibitors | 1 | 2018 | 6 | 0.05 | Why? |
| Teratoma | 1 | 2018 | 25 | 0.05 | Why? |
| Gene-Environment Interaction | 1 | 2019 | 127 | 0.05 | Why? |
| Codon, Nonsense | 1 | 2018 | 66 | 0.05 | Why? |
| Receptors, Dopamine | 1 | 2018 | 7 | 0.05 | Why? |
| Quantitative Trait Loci | 1 | 2020 | 340 | 0.05 | Why? |
| Catechol O-Methyltransferase | 1 | 2018 | 25 | 0.05 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 1 | 2020 | 8843 | 0.05 | Why? |
| Myelodysplastic Syndromes | 1 | 2021 | 261 | 0.05 | Why? |
| Electrophysiological Phenomena | 1 | 2018 | 59 | 0.05 | Why? |
| Dopamine Plasma Membrane Transport Proteins | 1 | 2018 | 37 | 0.05 | Why? |
| Biotransformation | 1 | 2018 | 74 | 0.05 | Why? |
| Receptor, Interferon alpha-beta | 1 | 2020 | 610 | 0.04 | Why? |
| Negative-Pressure Wound Therapy | 1 | 2018 | 66 | 0.04 | Why? |
| Protein Engineering | 1 | 2021 | 536 | 0.04 | Why? |
| Bone Marrow | 1 | 2021 | 492 | 0.04 | Why? |
| Dopamine Agonists | 1 | 2018 | 61 | 0.04 | Why? |
| Toll-Like Receptor 3 | 1 | 2020 | 391 | 0.04 | Why? |
| Electronic Nose | 1 | 2017 | 36 | 0.04 | Why? |
| Mice, Nude | 1 | 2018 | 340 | 0.04 | Why? |
| Heterozygote | 1 | 2018 | 249 | 0.04 | Why? |
| Dopamine | 1 | 2018 | 123 | 0.04 | Why? |
| Radiation Tolerance | 1 | 2016 | 25 | 0.04 | Why? |
| Biomechanical Phenomena | 1 | 2018 | 291 | 0.04 | Why? |
| Lectins, C-Type | 1 | 2020 | 405 | 0.04 | Why? |
| Myocardial Contraction | 1 | 2018 | 123 | 0.04 | Why? |
| Exons | 1 | 2017 | 158 | 0.04 | Why? |
| Cell Count | 1 | 2017 | 228 | 0.04 | Why? |
| Registries | 1 | 2017 | 12327 | 0.04 | Why? |
| SARS Virus | 1 | 2020 | 13021 | 0.04 | Why? |
| CpG Islands | 1 | 2017 | 230 | 0.04 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2020 | 12361 | 0.04 | Why? |
| Gene Deletion | 1 | 2018 | 430 | 0.04 | Why? |
| Protein Structure, Quaternary | 1 | 2017 | 455 | 0.04 | Why? |
| Genetic Markers | 1 | 2017 | 318 | 0.04 | Why? |
| Cell Transformation, Neoplastic | 1 | 2017 | 191 | 0.04 | Why? |
| Nerve Tissue Proteins | 1 | 2018 | 319 | 0.04 | Why? |
| Cytoplasm | 1 | 2016 | 304 | 0.04 | Why? |
| Promoter Regions, Genetic | 1 | 2019 | 823 | 0.04 | Why? |
| Drug Resistance | 1 | 2017 | 395 | 0.03 | Why? |
| Antigens, CD | 1 | 2020 | 984 | 0.03 | Why? |
| Syndrome | 1 | 2019 | 1310 | 0.03 | Why? |
| Diffusion Magnetic Resonance Imaging | 1 | 2016 | 317 | 0.03 | Why? |
| Gene Expression Regulation | 2 | 2017 | 4020 | 0.03 | Why? |
| Delivery of Health Care | 1 | 2020 | 15909 | 0.03 | Why? |
| Cell Nucleus | 1 | 2016 | 399 | 0.03 | Why? |
| Interferon-alpha | 1 | 2021 | 1442 | 0.03 | Why? |
| Cholesterol, LDL | 1 | 2017 | 499 | 0.03 | Why? |
| Drug Resistance, Neoplasm | 1 | 2016 | 447 | 0.03 | Why? |
| Homeostasis | 1 | 2016 | 582 | 0.03 | Why? |
| Mutation, Missense | 1 | 2018 | 863 | 0.03 | Why? |
| Cytochrome P450 Family 4 | 1 | 2011 | 7 | 0.03 | Why? |
| Mixed Function Oxygenases | 1 | 2011 | 13 | 0.03 | Why? |
| Africa South of the Sahara | 1 | 2017 | 1335 | 0.03 | Why? |
| Cytochrome P-450 CYP2C9 | 1 | 2011 | 25 | 0.03 | Why? |
| Receptors, Interleukin-6 | 1 | 2020 | 1383 | 0.03 | Why? |
| Antibodies, Viral | 2 | 2021 | 51949 | 0.03 | Why? |
| Vitamin K Epoxide Reductases | 1 | 2011 | 32 | 0.03 | Why? |
| Fatal Outcome | 1 | 2021 | 3438 | 0.03 | Why? |
| Antiviral Agents | 2 | 2021 | 41703 | 0.03 | Why? |
| Computational Biology | 2 | 2020 | 4514 | 0.03 | Why? |
| Cytochrome P-450 Enzyme System | 1 | 2011 | 144 | 0.03 | Why? |
| Complement Factor H | 1 | 2009 | 83 | 0.03 | Why? |
| Anticoagulants | 1 | 2011 | 9563 | 0.02 | Why? |
| Heart Ventricles | 1 | 2018 | 1139 | 0.02 | Why? |
| Sequence Analysis, DNA | 1 | 2017 | 2830 | 0.02 | Why? |
| Atherosclerosis | 1 | 2017 | 768 | 0.02 | Why? |
| Binding Sites | 1 | 2021 | 6201 | 0.02 | Why? |
| Infant | 2 | 2021 | 30274 | 0.02 | Why? |
| Cell Line, Tumor | 1 | 2016 | 3608 | 0.02 | Why? |
| HEK293 Cells | 1 | 2021 | 8394 | 0.02 | Why? |
| Molecular Targeted Therapy | 1 | 2017 | 1579 | 0.02 | Why? |
| Kaplan-Meier Estimate | 1 | 2017 | 4260 | 0.02 | Why? |
| Leukocytes, Mononuclear | 1 | 2017 | 2115 | 0.02 | Why? |
| Multivariate Analysis | 1 | 2018 | 5440 | 0.02 | Why? |
| Preoperative Care | 1 | 2016 | 1515 | 0.02 | Why? |
| Oxidative Stress | 1 | 2017 | 2050 | 0.02 | Why? |
| Cells, Cultured | 1 | 2017 | 5835 | 0.02 | Why? |
| Iran | 1 | 2018 | 5467 | 0.02 | Why? |
| Germ-Line Mutation | 1 | 2005 | 86 | 0.02 | Why? |
| Pilot Projects | 1 | 2017 | 5182 | 0.02 | Why? |
| Arrhythmias, Cardiac | 1 | 2018 | 2510 | 0.02 | Why? |
| Family | 1 | 2018 | 2909 | 0.02 | Why? |
| Wounds and Injuries | 1 | 2017 | 1708 | 0.02 | Why? |
| Immunity, Innate | 1 | 2021 | 6570 | 0.02 | Why? |
| Brain | 1 | 2020 | 5133 | 0.02 | Why? |
| DNA Mutational Analysis | 1 | 2005 | 581 | 0.02 | Why? |
| Prospective Studies | 2 | 2018 | 43301 | 0.01 | Why? |
| RNA, Messenger | 1 | 2017 | 5131 | 0.01 | Why? |
| Point Mutation | 1 | 2005 | 481 | 0.01 | Why? |
| Asymptomatic Infections | 1 | 2020 | 7218 | 0.01 | Why? |
| Treatment Outcome | 2 | 2018 | 51732 | 0.01 | Why? |
| Signal Transduction | 1 | 2017 | 7207 | 0.01 | Why? |
| Family Health | 1 | 2005 | 731 | 0.01 | Why? |
| Biomedical Research | 1 | 2020 | 5270 | 0.01 | Why? |
| Risk Factors | 2 | 2019 | 71621 | 0.01 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2020 | 9335 | 0.01 | Why? |
| Immunoglobulin G | 1 | 2021 | 21571 | 0.01 | Why? |
| Base Sequence | 1 | 2005 | 3581 | 0.01 | Why? |
| Pregnancy | 1 | 2017 | 23879 | 0.01 | Why? |
| Polymerase Chain Reaction | 1 | 2009 | 6740 | 0.01 | Why? |
| Biomarkers | 1 | 2017 | 23361 | 0.01 | Why? |
| Cohort Studies | 1 | 2017 | 36005 | 0.01 | Why? |
| Lung | 1 | 2021 | 31049 | 0.01 | Why? |
| Tomography, X-Ray Computed | 1 | 2016 | 25144 | 0.01 | Why? |
| Neoplasms | 1 | 2017 | 17251 | 0.01 | Why? |
| Retrospective Studies | 1 | 2016 | 105322 | 0.00 | Why? |